Improving quality in economic evaluations of the management of schizophrenia

References

• Advisory Committee on Health Technology Assessment. Assessing the Effects of HealthTechnologies: Principles, Practice and Proposals. London: HMSO, 1992
   Google Scholar
• Department of Health. The New NHS. Modern. Dependable. London: HMSO, 1997
   Google Scholar
• Drummond M, Cooke J, Walley T. Economic Evaluation in Health Care Decision Making: Evidence from the UK. York: University of York, Centre for Health Economics, 1996
   Google Scholar
• Lee JT, Sanchez LA. Interpretation of ‘cost-effective’ and soundness of economic evaluations in the pharmacy literature. Am J Hosp Pharm 1991; 48: 2622–7
   PubMedGoogle Scholar
• Udvarhelyi IS, Colditz GA, Rai A et al. Cost-effectiveness and cost-benefit analysis in the medical literature: are methods being used correctly? Ann Intern Med 1992; 116: 238–44
   PubMed Web of Science ®Google Scholar
• Adams ME, McCall NT, Gray DT et al. Economic analysis in randomised controlled trials. Med Care 1992; 30: 231–43
   PubMed Web of Science ®Google Scholar
• Gerard K. Cost-utility in practice: a policy maker’s guide to the state of the art. Health Policy 1992; 21: 249–79
   PubMed Web of Science ®Google Scholar
• Evers S, Van Wijk A, Ament A. Economic evaluation of mental health care interventions: A review. Health Econ 1997; 6: 161–77
   PubMed Web of Science ®Google Scholar
• Williams A. The cost benefit approach. Br Med Bull 1974; 30: 252–56
   PubMedGoogle Scholar
• Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. New Eng J Med 19 77; 296: 716–21
   Google Scholar
• Guyatt G, Drummond MF, Feeny D et al. Guidelines for the clinical and economic evaluation of health care technologies. Soc Sci Med 1986; 22(4): 398–408
   Google Scholar
• Luce BR, Elixhauser A. Standards for the socio-economic evaluation of health care products. Springer-Verlaag, Berlin, 1990
   Google Scholar
• Rovira J. Standardising economic appraisal of health technology in the European Community. Soc Sci Med 1994; 38(12): 1675–8
   Google Scholar
• Drummond MF, Brandt A, Luce B, et al. Standardising methodologies for economic evaluation in health care. Practice, problems and potential. Int J Technol Assess Health Care 1993; 9(1): 26–36
   Google Scholar
• NHS Centres for Reviews and Dissemination. Database of abstracts of reviews of effectiveness (DARE). University of York, 1997
   Google Scholar
• Department of Health. Register of cost-effectiveness studies. University of York, 1994
   Google Scholar
• NHS Centres for Reviews and Dissemination, NHS economic evaluation database (NEED). University of York, 1997
   Google Scholar
• Commonwealth of Australia Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses. Department of Health, Housing and Community Services. Canberra, 1990
   Google Scholar
• Ontario Ministry of Health Guidelines for the preparation of economic analysis to be included in submission to the Drugs Program branch for listing in the Ontario Drug Benefit formulary/Comparative drug index. Ministry of Health, Toronto, 1991
   Google Scholar
• Office of Health Economics (OHE)/ International federation of pharmaceutical manufacturers association (IFPMA), Heath Economics Evaluation database (HEED). OHE, London, 1997
   Google Scholar
• Drummond M, Jefferson T et al. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313: 275–83
   PubMed Web of Science ®Google Scholar
• Burdens of Disease. NHS Executive, 1996
   Google Scholar
• Andreasen, N. Assessment issues and the cost of schizophrenia. Schizophr Bull 1991; 17(3): 475–81
   Google Scholar
• Davies L, Drummond M. Economics and schizophrenia: the real cost. Br J Psychiatry 1994; 165 (suppl. 25): 18–21
   Google Scholar
• Knapp M, Beecham J. Reduced list costings: examination of an informed shortcut in mental health research. Health Econ 1993; 2: 313–22
   PubMedGoogle Scholar
• Knapp. M. Costs of schizophrenia. Br J Psychiatry 1997; 171: 509–518
   PubMed Web of Science ®Google Scholar
• World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: WHO, 1992
   Google Scholar
• Gold MR, Russell LB, Weinvtein MC. Cost-effectiveness in Health and Medicine. Oxford University Press, 1996
   Google Scholar
• Birch S, Gafni A. Cost-effectiveness ratios: in a league of their own. Health Policy 1994; 28: 133–41
   PubMed Web of Science ®Google Scholar
• Knapp M, Beecham J. Costing mental health services. Psychol Med 1990; 20: 893–908
   PubMed Web of Science ®Google Scholar
• Van Os J. (Genetic) epidemiology as a tool to identify risk factors for emergence and persistence of illness in the functional psychoses. International Institute for Psycho-social and Socio-ecological Research. 1996
   Google Scholar
• Kendell R. Clinical validity. Psychol Med 1989; 19: 45–55
   PubMed Web of Science ®Google Scholar
• Wilkinson G, Williams B, Krekorian K et al. QALY’s in mental health: a case study. Psychol Med 1992; 22: 725–31
   PubMed Web of Science ®Google Scholar
• Karlsson G, Johannesson M. The decision rules of cost-effectiveness analysis. Pharmacoeconomics 1996; 9(2): 113–20
   Google Scholar
• Sugden R, Williams A. The principles of practical cost-benefit analysis. Oxford University Press, Oxford, 1978
   Google Scholar
• Department of Health. Press release 94/251, 1994
   Google Scholar
• Gold ME, Siegel JE, Russell LB et al. Cost-effectiveness in health and medicine. Oxford University Press, New York, 1996
   Google Scholar
• Parsonage M. and Neuburger H. Discounting and health benefits. Health Econ 1992; 1: 71–79
   PubMedGoogle Scholar
• Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95–104
   PubMed Web of Science ®Google Scholar
• Jadad, A R, Moore R A, Carroll, D. Assessing the quality of reports of RCT’s: is blinding necessary? Controlled Clinical Trials 1996; 17(1): 1–12
   Google Scholar
• Gray A, Marshall M, Lockwood A, et al. Problems in conducting economic evaluations alongside clinical trials. Br J Psychiatry 1997; 170: 47–52
   PubMed Web of Science ®Google Scholar
• Wolff N, Helminiak T, Tebes J. Getting the cost right in cost-effectiveness analyses. Am J Psychiatry 1997; 154: 736–43
   PubMed Web of Science ®Google Scholar